SCHEMBL12812431

SCHEMBL12812431

Nc1cccc(N2CCN(c3cnc4ccc(-c5ccc(O)cc5)cc4n3)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
MAPT P10636 4/20 0.49
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
NFKB1 P19838 1/20 0.49
HTT P42858 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
HCAR2 Q8TDS4 3/20 0.43
KDM4E B2RXH2 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
DHFR P00374 3/20 0.41
ADRA2C P18825 1/20 0.41
PIK3CA P42336 2/20 0.41
PIK3CD O00329 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1442297 0.88 MAPT (0.64) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL12812430 0.85 NPC1 (0.53) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1443737 0.85 DHFR (0.46) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL10179577 0.85 MET (0.51) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL12811968 0.82 NPC1 (0.49) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1443390 0.81 PIK3CA (0.47) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL1442666 0.81 HRH4 (0.59) ALDH1A1SMN1; SMN2HPGDHCAR2HTR3A
SCHEMBL1444121 0.80 PIK3CA (0.48) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL12811964 0.80 BCHE (0.51) NPC1RAB9AMAPTALDH1A1SMN1; SMN2
SCHEMBL13276461 0.79 HCAR2 (0.43) NPC1RAB9AMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011026579-A1 SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-10 WO disclosed